Drugs@FDA application record, NDA 020262 (TAXOL, paclitaxel injection) (1992)

Government Record · U.S. Food and Drug Administration, Center for Drug Evaluation and Research · December 29, 1992

U.S. Food et al., 1992-12-29: FDA application record for Taxol showing an original approval dated 29 December 1992; HQ Specialty Pharma is the current holder.

12/29/1992

HTML record, unpaginated

U.S. Food et al., 1992-12-29: FDA application record for Taxol showing an original approval dated 29 December 1992; HQ Specialty Pharma is the current holder. Funder/conflicts: n/a. Maker: 1992 sponsor was Bristol-Myers Squibb (see CHI-24, CHI-34, CHI-35); current holder differs. Comparator: n/a. FDA's Orange Book patent file for NDA 020262 contains no unexpired patents at the time of retrieval; GAO found NIH held no patent on paclitaxel itself (CHI-34). Study type: regulatory record.